Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

/p>

369,701$

315,721Collaborative agreement revenues1753556822,379Royalty and license revenues2,9622,7755,8846,556Total revenues101,61487,081376,267324,656OPERATING EXPENSES:Cost of sales (excludes amortization of developed
product technology)20,46916,72970,28565,909Research and development42,19727,443147,309115,116Selling, general and administrative42,09836,528151,723124,290Intangible asset amortization and contingent consideration200—6,4062,914Total operating expenses104,96480,700375,723308,229INCOME (LOSS) FROM CONTINUING OPERATIONS(3,350)6,38154416,427Equity in the loss of BioMarin/Genzyme LLC(797)(821)(2,991)(2,594)Interest income9191,0354,1125,086Interest expense(2,257)(2,715)(10,329)(14,090)Debt conversion expense (13,728)-(13,728)-Impairment loss on equity investments---(5,848)Net gain (loss) from sale of investments(25)-9021,585INCOME (LOSS) BEFORE INCOME TAXES(19,238)3,880(21,490)566Provision for (benefit from) income taxes(7,049)(831)(227,309)1,054NET INCOME (LOSS)$

(12,189)$

4,711$

205,819$

(488)NET INCOME (LOSS) PER SHARE, BASIC$

(0.11)$

0.05$

1.99$

(0.00)NET INCOME (LOSS) PER SHARE, DILUTED$

(0.11)$

0.05$

1.73$

(0.00)Weighted average common shares outstanding, basic107,344100,768103,093100,271Weighted average common shares outstanding, diluted107,344102,454125,674100,271(1) December 31, 2009 balances were derived from the audited consolidated financial statements.Appendix A – Non-GAAP Adjusted EBITDA for 2010 and 2009Reconciliation of GAAP Net Income (Loss) to EBITDA and Adjusted EBITDAFor the Four Quarters and Fiscal Year 2010 (and 2011 Guidance)(in millions)(unaudited) 2010Three Months EndedYear Ended DecemberYear Ending
December 31, 2011NOTESMarch 31June 30September 30December 3131, 2010GuidanceGAAP Net Income/(Loss)$
.2$
(0.5)$
217.3$
(12.2)$
205.8 $(60) - $(48) Interest expense, net1.21.62.01.46.2 6 Income
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)...  LCA-Vision Inc. (NASDAQ: LCAV ), a leading ... ® brand, announces that all nominees to the company,s Board ... meeting of stockholders.  These Directors are: , ... & Gaynor Investment Counsel , John C. ... Edgar F. Heizer III , Chairman of Manus ...
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... PRINCETON, N.J. , May 21, 2013 /PRNewswire/ ... consulting company, today announced that 13-year veteran ... Chief Executive Officer. Geraghty,s experience includes more than ... senior management positions with manufacturing organizations. He succeeds ... retiring after serving as Kepner-Tregoe,s Chairman of the ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3
(Date:5/21/2013)... 21, 2013 Children using the ... Inc., experience audiological results comparable to the traditionally ... fewer complications, according to a new study. , ... Sophono’s abutment-free technology performs just as well as ... many fewer complications,” says Jim Kasic, president and ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... between two international powerhouse teams - the game between ... this coming 23rd of May 2013. These two teams ... soccer and they are bringing their A-game to the Busch ... team. , This will be the first time that a ...
(Date:5/21/2013)... The risk of sudden infant death syndrome (SIDS) is ... a new study finds. British researchers noted that ... do not drink, use illegal drugs or smoke. They ... cause of infant death in developed countries, would drop ... In the United States, all parents are advised ...
(Date:5/21/2013)... tobacco packages in order to reduce consumption do not ... find some of them really unpleasant. So, if the ... anti-smoking campaigns, it should produce a new set of ... some of the conclusions of research conducted in the ... University of Granada by Miguel ngel Muoz, Luis Ciria ...
(Date:5/21/2013)... Grapefruits have long been known for their ... how medical therapies like anti-cancer drugs are delivered ... researchers have uncovered how to create nanoparticles using ... how to use them as drug delivery vehicles. ... Ph.D., and their team today (May 21, 2013), ...
Breaking Medicine News(10 mins):Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2Health News:Warning images for cigarette packs proposed by Europe do not make enough emotional impact 2Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2
... the powers of digital communications technology to help young ... chemotherapy. , They have given the teenagers and ... patients can record and send details of all their ... phones are capable of giving basic advice about the ...
... Endocrine Society will present Ronald S. Swerdloff, M.D., ... Institute at Harbor-UCLA Medical Center (LA BioMed), with ... June 15-18 in San Francisco. , The Endocrine ... the full range of disciplines associated with endocrinology, ...
... study cut desire, relapse in as little as 10 ... new treatment that reduces excessive drinking and prevents drinking ... study finds. , The treatment involves increasing levels of ... -- also being looked at as a treatment for ...
... Monday, Dad begins,to put a lot on his plate at work ... he works to keep the bacon off his plate., Here,s ... by over,2 to 1. It,s no secret that millions of men ... harmful number. High,cholesterol has been linked to a number of health ...
... Announce Plans for Celebrating World Blood Donor,Day on ... To increase national,and global appreciation of volunteer blood ... (ADRP) are partnering together to,encourage their respective members ... 14. This specific day marks the birthday of ...
... and ... the healthcare industry, LANSDALE, Pa., ... process is a big issue facing healthcare reform, says,NAIRO (National ... 44 states and Washington, D.C. have external,review laws, each is ...
Cached Medicine News:Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 3Health News:LA BioMed investigator wins Distinguished Educator Award 2Health News:New Treatment Shows Promise for Excessive Drinking 2Health News:Take the Fat Out of Father's Day! 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 3Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 4Health News:NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 2
... Vibratome, this sapphire microtomy knife makes it ... thin Vibratome sections with microscopic resolution similar ... plastic sections. The sapphire knife allows ... a thickness in the 6-10 micron range ...
... an optional component available for Vibratome ... plugs into the back of all ... a selector switch. Once activated, ... initiating a sectioning sequence and reversing ...
... inside the existing black Vibratome bath. This ... buffer and ice kept in the original black ... has round mounting disks that can be easily ... bath surface are marked with degrees of rotation ...
... simple device designed to mount floated histological ... facilitates the mounting of all types of ... especially useful for mounting tissue slices not ... produced with a Vibratome, freezing microtome (cryostat) ...
Medicine Products: